158 related articles for article (PubMed ID: 11943586)
1. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.
Mägert HJ; Kreutzmann P; Ständker L; Walden M; Drögemüller K; Forssmann WG
Int J Biochem Cell Biol; 2002 Jun; 34(6):573-6. PubMed ID: 11943586
[TBL] [Abstract][Full Text] [Related]
2. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
[TBL] [Abstract][Full Text] [Related]
3. LEKTI, a novel 15-domain type of human serine proteinase inhibitor.
Mägert HJ; Ständker L; Kreutzmann P; Zucht HD; Reinecke M; Sommerhoff CP; Fritz H; Forssmann WG
J Biol Chem; 1999 Jul; 274(31):21499-502. PubMed ID: 10419450
[TBL] [Abstract][Full Text] [Related]
4. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
[TBL] [Abstract][Full Text] [Related]
5. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
[TBL] [Abstract][Full Text] [Related]
6. Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI.
Walden M; Kreutzmann P; Drögemüller K; John H; Forssmann WG; Hans-Jürgen M
Biol Chem; 2002; 383(7-8):1139-41. PubMed ID: 12437098
[TBL] [Abstract][Full Text] [Related]
7. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor.
Kreutzmann P; Schulz A; Ständker L; Forssmann WG; Mägert HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):75-81. PubMed ID: 15026000
[TBL] [Abstract][Full Text] [Related]
8. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
Raghunath M; Tontsidou L; Oji V; Aufenvenne K; Schürmeyer-Horst F; Jayakumar A; Ständer H; Smolle J; Clayman GL; Traupe H
J Invest Dermatol; 2004 Sep; 123(3):474-83. PubMed ID: 15304086
[TBL] [Abstract][Full Text] [Related]
9. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
Meyer-Hoffert U; Wu Z; Schröder JM
PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
[TBL] [Abstract][Full Text] [Related]
10. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
Komatsu N; Takata M; Otsuki N; Ohka R; Amano O; Takehara K; Saijoh K
J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
[TBL] [Abstract][Full Text] [Related]
11. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
[TBL] [Abstract][Full Text] [Related]
12. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
[TBL] [Abstract][Full Text] [Related]
13. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.
Jayakumar A; Kang Y; Henderson Y; Mitsudo K; Liu X; Briggs K; Wang M; Frederick MJ; El-Naggar AK; Bebök Z; Clayman GL
Arch Biochem Biophys; 2005 Mar; 435(1):89-102. PubMed ID: 15680911
[TBL] [Abstract][Full Text] [Related]
14. SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.
Tartaglia-Polcini A; Bonnart C; Micheloni A; Cianfarani F; Andrè A; Zambruno G; Hovnanian A; D'Alessio M
J Invest Dermatol; 2006 Feb; 126(2):315-24. PubMed ID: 16374478
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
[TBL] [Abstract][Full Text] [Related]
16. A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome.
Chao SC; Tsai YM; Lee JY
J Formos Med Assoc; 2003 Jun; 102(6):418-23. PubMed ID: 12923596
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of a severe case of Netherton syndrome and application for prenatal testing.
Müller FB; Hausser I; Berg D; Casper C; Maiwald R; Jung A; Jung H; Korge BP
Br J Dermatol; 2002 Mar; 146(3):495-9. PubMed ID: 11952552
[TBL] [Abstract][Full Text] [Related]
18. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.
Bitoun E; Micheloni A; Lamant L; Bonnart C; Tartaglia-Polcini A; Cobbold C; Al Saati T; Mariotti F; Mazereeuw-Hautier J; Boralevi F; Hohl D; Harper J; Bodemer C; D'Alessio M; Hovnanian A
Hum Mol Genet; 2003 Oct; 12(19):2417-30. PubMed ID: 12915442
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
